Vistagen Therapeutics Inc
(NAS:VTGN)
$
3.67
0.02 (0.55%)
Market Cap: 99.29 Mil
Enterprise Value: -7.08 Mil
PE Ratio: 0
PB Ratio: 0.95
GF Score: 30/100 Vistagen Therapeutics Inc (VTGN) Transcripts
- Q4 2024 Vistagen Therapeutics Inc Earnings Call TranscriptJun 11, 2024$3.77 (+2.45%)Earnings
- Q3 2024 Vistagen Therapeutics Inc Earnings Call TranscriptFeb 13, 2024$4.9 (-4.85%)Earnings
- Q2 2024 Vistagen Therapeutics Inc Earnings Call TranscriptNov 09, 2023$2.89 (-6.17%)Earnings
- Q1 2024 Vistagen Therapeutics Inc Earnings Call TranscriptAug 10, 2023$7.52 (+6.82%)Earnings
- Q4 2023 Vistagen Therapeutics Inc Earnings Call TranscriptJun 28, 2023$1.72 (+1.78%)Earnings
- Q3 2023 VistaGen Therapeutics Inc Earnings Call TranscriptFeb 07, 2023$7.82 (+4.53%)Earnings
- Q2 2023 VistaGen Therapeutics Inc Earnings Call TranscriptNov 10, 2022$3.9 (+15.45%)Earnings
- VistaGen Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q1 2023 VistaGen Therapeutics Inc Earnings Call TranscriptAug 11, 2022$5.25 (+2.40%)Earnings
- Q4 2022 VistaGen Therapeutics Inc Earnings Call TranscriptJun 23, 2022$31.2 (+1.96%)Earnings
- Q3 2022 VistaGen Therapeutics Inc Earnings Call TranscriptFeb 10, 2022$46.2 (-4.94%)Earnings
- 1